Mathias Gelderblom

Dr. Mathias Gelderblom is an Executive Senior Physician and Medical Specialist in Neurology at the University Medical Center Hamburg-Eppendorf (UKE), affiliated with the Faculty of Medicine at the University of Hamburg. He holds the academic rank of Senior Lecturer and is part of the Head and Neurocenter Department of Neurology. His research focuses on neuroimmunology, stroke mechanisms, and movement disorders such as dystonia. Dr. Gelderblom’s work bridges clinical practice and translational research, addressing topics like inflammatory responses in ischemic stroke, neurodegenerative pathways, and genetic underpinnings of neurological diseases.

His studies often integrate clinical data with molecular and immunological analyses, contributing to understanding conditions like cerebral vasculitis, peripheral neuropathies, and the role of cytokines such as IL-17A in neurological disorders. Collaborative projects include multi-center trials investigating immunotherapies for stroke and large-scale genetic screening for dystonia. Dr. Gelderblom’s expertise spans both clinical diagnostics and experimental research, with a focus on advancing treatments for neuroinflammatory and neurodegenerative conditions.

Key research themes include stroke pathophysiology, neuroimmunological interactions, and translational applications of immunomodulatory therapies. His publications highlight advancements in understanding the role of dendritic cells, cytokine networks, and genetic factors in neurological diseases, with implications for precision medicine and patient outcomes.